227 related articles for article (PubMed ID: 26428370)
1. EBNA1.
Frappier L
Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
3. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.
Lin A; Wang S; Nguyen T; Shire K; Frappier L
J Virol; 2008 Dec; 82(24):12009-19. PubMed ID: 18922874
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
[TBL] [Abstract][Full Text] [Related]
6. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.
Cao JY; Mansouri S; Frappier L
J Virol; 2012 Jan; 86(1):382-94. PubMed ID: 22013061
[TBL] [Abstract][Full Text] [Related]
7. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8.
Do NV; Ingemar E; Phi PT; Jenny A; Chinh TT; Zeng Y; Hu L
Virus Res; 2008 Mar; 132(1-2):15-24. PubMed ID: 18096263
[TBL] [Abstract][Full Text] [Related]
8. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
10. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function.
Duellman SJ; Thompson KL; Coon JJ; Burgess RR
J Gen Virol; 2009 Sep; 90(Pt 9):2251-9. PubMed ID: 19439552
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
[TBL] [Abstract][Full Text] [Related]
13. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
15. The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1.
Wu H; Ceccarelli DF; Frappier L
EMBO Rep; 2000 Aug; 1(2):140-4. PubMed ID: 11265753
[TBL] [Abstract][Full Text] [Related]
16. Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.
Ceccarelli DF; Frappier L
J Virol; 2000 Jun; 74(11):4939-48. PubMed ID: 10799567
[TBL] [Abstract][Full Text] [Related]
17. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation.
Shire K; Kapoor P; Jiang K; Hing MN; Sivachandran N; Nguyen T; Frappier L
J Virol; 2006 Jun; 80(11):5261-72. PubMed ID: 16699006
[TBL] [Abstract][Full Text] [Related]
19. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus.
Zhang D; Frappier L; Gibbs E; Hurwitz J; O'Donnell M
Nucleic Acids Res; 1998 Jan; 26(2):631-7. PubMed ID: 9421526
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
Murakami M; Lan K; Subramanian C; Robertson ES
J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]